US to impose steep tariffs on generic medicine imports from Aug 2028

WASHINGTON: (Jul 22) US President Donald Trump on Wednesday announced plans to onshore drug manufacturing by keeping tariffs on imported generic medicines at zero per cent for two years before raising them to 100 per cent in August 2028 and 200 per cent thereafter — a move that could impact India.

India is the largest exporter of generic drugs to the US.

In a post on Truth Social, Trump said beginning August 1, the US will continue to have a zero per cent tariff on all generic drugs brought into the country for two years, after which it will be raised to 100 per cent for one year, and 200 per cent thereafter.

Source: PTI News

Digitalmitra